Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.79532390 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.72309687 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.72309687 |
4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.66968525 |
5 | regulation of gamma-delta T cell activation (GO:0046643) | 3.81932458 |
6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.66157434 |
7 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.57617487 |
8 | positive thymic T cell selection (GO:0045059) | 3.55402341 |
9 | positive regulation of interferon-alpha production (GO:0032727) | 3.53543192 |
10 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.33590388 |
11 | regulation of interferon-alpha production (GO:0032647) | 3.33189807 |
12 | response to type I interferon (GO:0034340) | 3.31321769 |
13 | regulation of T cell tolerance induction (GO:0002664) | 3.27960425 |
14 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.27901087 |
15 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.26580260 |
16 | type I interferon signaling pathway (GO:0060337) | 3.24091134 |
17 | cellular response to type I interferon (GO:0071357) | 3.24091134 |
18 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.23396424 |
19 | myeloid dendritic cell differentiation (GO:0043011) | 3.22477467 |
20 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.21611337 |
21 | modulation by symbiont of host defense response (GO:0052031) | 3.18948425 |
22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.18948425 |
23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.18948425 |
24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.18948425 |
25 | modulation by symbiont of host immune response (GO:0052553) | 3.18948425 |
26 | positive regulation by symbiont of host defense response (GO:0052509) | 3.18948425 |
27 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.18609788 |
28 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.17874283 |
29 | necroptotic process (GO:0070266) | 3.13308503 |
30 | negative thymic T cell selection (GO:0045060) | 3.06207649 |
31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.04392084 |
32 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.03723297 |
33 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.98742191 |
34 | thymic T cell selection (GO:0045061) | 2.94045868 |
35 | negative T cell selection (GO:0043383) | 2.93182709 |
36 | sphingosine metabolic process (GO:0006670) | 2.92923524 |
37 | melanin metabolic process (GO:0006582) | 2.92616503 |
38 | regulation of B cell differentiation (GO:0045577) | 2.92245585 |
39 | positive regulation of humoral immune response (GO:0002922) | 2.92054974 |
40 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.90274383 |
41 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.88965297 |
42 | defense response to protozoan (GO:0042832) | 2.87820180 |
43 | negative regulation of viral genome replication (GO:0045071) | 2.85835482 |
44 | I-kappaB phosphorylation (GO:0007252) | 2.85317265 |
45 | positive regulation of interferon-beta production (GO:0032728) | 2.83616480 |
46 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.81340627 |
47 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.80922205 |
48 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.76490575 |
49 | melanin biosynthetic process (GO:0042438) | 2.75279166 |
50 | response to protozoan (GO:0001562) | 2.73149579 |
51 | response to laminar fluid shear stress (GO:0034616) | 2.72939825 |
52 | cellular response to virus (GO:0098586) | 2.72375569 |
53 | germinal center formation (GO:0002467) | 2.72070519 |
54 | response to muramyl dipeptide (GO:0032495) | 2.67159274 |
55 | positive regulation of antigen processing and presentation (GO:0002579) | 2.66583565 |
56 | regulation of chronic inflammatory response (GO:0002676) | 2.66032260 |
57 | myeloid dendritic cell activation (GO:0001773) | 2.65801647 |
58 | regulation of podosome assembly (GO:0071801) | 2.65219632 |
59 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.63271368 |
60 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.63264101 |
61 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.61071760 |
62 | T cell selection (GO:0045058) | 2.60679424 |
63 | interferon-gamma production (GO:0032609) | 2.59434200 |
64 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.59108704 |
65 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.58407984 |
66 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.58208424 |
67 | detection of molecule of bacterial origin (GO:0032490) | 2.58026053 |
68 | response to peptidoglycan (GO:0032494) | 2.57956884 |
69 | positive T cell selection (GO:0043368) | 2.55845258 |
70 | NIK/NF-kappaB signaling (GO:0038061) | 2.55827237 |
71 | regulation of vitamin metabolic process (GO:0030656) | 2.55691579 |
72 | * negative regulation of viral release from host cell (GO:1902187) | 2.53868356 |
73 | detection of bacterium (GO:0016045) | 2.52130782 |
74 | indole-containing compound catabolic process (GO:0042436) | 2.51273055 |
75 | indolalkylamine catabolic process (GO:0046218) | 2.51273055 |
76 | tryptophan catabolic process (GO:0006569) | 2.51273055 |
77 | negative regulation of cell killing (GO:0031342) | 2.50665675 |
78 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.50665675 |
79 | T cell migration (GO:0072678) | 2.49860768 |
80 | regulation of RIG-I signaling pathway (GO:0039535) | 2.49180359 |
81 | B cell receptor signaling pathway (GO:0050853) | 2.48982277 |
82 | cellular response to interferon-alpha (GO:0035457) | 2.47634697 |
83 | response to interferon-alpha (GO:0035455) | 2.47405658 |
84 | B cell mediated immunity (GO:0019724) | 2.47192274 |
85 | diol metabolic process (GO:0034311) | 2.47057919 |
86 | macrophage activation involved in immune response (GO:0002281) | 2.44345569 |
87 | regulation of tolerance induction (GO:0002643) | 2.43799682 |
88 | T cell lineage commitment (GO:0002360) | 2.43628688 |
89 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.43300710 |
90 | detection of other organism (GO:0098543) | 2.42819304 |
91 | leukocyte aggregation (GO:0070486) | 2.42174886 |
92 | cellular response to interferon-gamma (GO:0071346) | 2.42024336 |
93 | N-acetylneuraminate metabolic process (GO:0006054) | 2.41735946 |
94 | natural killer cell differentiation (GO:0001779) | 2.40041841 |
95 | programmed necrotic cell death (GO:0097300) | 2.39960197 |
96 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.39792922 |
97 | regulation of interferon-beta production (GO:0032648) | 2.39158283 |
98 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.38769599 |
99 | defense response to virus (GO:0051607) | 2.36938645 |
100 | positive regulation of type 2 immune response (GO:0002830) | 2.36683191 |
101 | positive regulation of extracellular matrix organization (GO:1903055) | 2.35984511 |
102 | keratinocyte development (GO:0003334) | 2.35793252 |
103 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.35730995 |
104 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.35464386 |
105 | regulation of cholesterol storage (GO:0010885) | 2.34388918 |
106 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.33781520 |
107 | kynurenine metabolic process (GO:0070189) | 2.32909343 |
108 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.32732724 |
109 | immunoglobulin mediated immune response (GO:0016064) | 2.32244353 |
110 | tryptophan metabolic process (GO:0006568) | 2.32045021 |
111 | negative regulation of granulocyte differentiation (GO:0030853) | 2.32042052 |
112 | lactate metabolic process (GO:0006089) | 2.31857667 |
113 | response to interferon-gamma (GO:0034341) | 2.31337371 |
114 | regulation of antigen processing and presentation (GO:0002577) | 2.31079414 |
115 | regulation of histone H3-K27 methylation (GO:0061085) | 2.30113926 |
116 | positive regulation of p38MAPK cascade (GO:1900745) | 2.29947687 |
117 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.29690218 |
118 | mammary gland epithelial cell proliferation (GO:0033598) | 2.29100688 |
119 | positive regulation of cholesterol efflux (GO:0010875) | 2.28642924 |
120 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.27558872 |
121 | * negative regulation of viral process (GO:0048525) | 2.27420841 |
122 | positive regulation of tolerance induction (GO:0002645) | 2.27096215 |
123 | phospholipid efflux (GO:0033700) | 2.26696856 |
124 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.26547646 |
125 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.26056166 |
126 | necrotic cell death (GO:0070265) | 2.25511522 |
127 | aromatic amino acid family catabolic process (GO:0009074) | 2.25074239 |
128 | tolerance induction (GO:0002507) | 2.25030299 |
129 | cellular response to interleukin-15 (GO:0071350) | 2.24729742 |
130 | negative regulation of interleukin-12 production (GO:0032695) | 2.24648931 |
131 | positive regulation of B cell differentiation (GO:0045579) | 2.24421916 |
132 | regulation of viral genome replication (GO:0045069) | 2.24076942 |
133 | ER overload response (GO:0006983) | 2.22949583 |
134 | negative regulation of bone resorption (GO:0045779) | 2.22685664 |
135 | response to host immune response (GO:0052572) | 2.21937725 |
136 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.21937725 |
137 | pinocytosis (GO:0006907) | 2.19035685 |
138 | regulation of defense response to virus by host (GO:0050691) | 2.17986556 |
139 | positive regulation of interleukin-12 production (GO:0032735) | 2.17616664 |
140 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.17548088 |
141 | T cell apoptotic process (GO:0070231) | 2.17321746 |
142 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.17256646 |
143 | T-helper cell differentiation (GO:0042093) | 2.17256646 |
144 | positive regulation of cholesterol transport (GO:0032376) | 2.17206678 |
145 | positive regulation of sterol transport (GO:0032373) | 2.17206678 |
146 | Rap protein signal transduction (GO:0032486) | 2.17117121 |
147 | response to interleukin-15 (GO:0070672) | 2.16621161 |
148 | regulation of extracellular matrix disassembly (GO:0010715) | 2.16109446 |
149 | regulation of superoxide anion generation (GO:0032928) | 2.14977193 |
150 | regulation of cholesterol homeostasis (GO:2000188) | 2.14801642 |
151 | protein carboxylation (GO:0018214) | 2.14516957 |
152 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.14516957 |
153 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.13475756 |
154 | phospholipid homeostasis (GO:0055091) | 2.13180405 |
155 | detection of external biotic stimulus (GO:0098581) | 2.12913510 |
156 | regulation of response to interferon-gamma (GO:0060330) | 2.12226922 |
157 | response to host (GO:0075136) | 2.11032764 |
158 | response to host defenses (GO:0052200) | 2.11032764 |
159 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.11032764 |
160 | complement activation, alternative pathway (GO:0006957) | 2.10886476 |
161 | regulation of interleukin-12 production (GO:0032655) | 2.10556515 |
162 | negative regulation of cholesterol transport (GO:0032375) | 2.09899679 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.60278071 |
2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.45730929 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.41829441 |
4 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.54804098 |
5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.37489669 |
6 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.22095004 |
7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.20335008 |
8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.05491446 |
9 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.99152322 |
10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.89229011 |
11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.68469727 |
12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.68080749 |
13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.50131996 |
14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.42542098 |
15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.33591390 |
16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.33012905 |
17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28322285 |
18 | MYC_22102868_ChIP-Seq_BL_Human | 2.24753861 |
19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.24304488 |
20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19022136 |
21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.18375379 |
22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.16306393 |
23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.12291258 |
24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.09082922 |
25 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.01183857 |
26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.98503938 |
27 | MAF_26560356_Chip-Seq_TH1_Human | 1.96328889 |
28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.95196066 |
29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.87311728 |
30 | MYB_26560356_Chip-Seq_TH1_Human | 1.82199679 |
31 | MYB_26560356_Chip-Seq_TH2_Human | 1.76658221 |
32 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.76593161 |
33 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.71565766 |
34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.71051563 |
35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.68757302 |
36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68474264 |
37 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.66226734 |
38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62576496 |
39 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.62466383 |
40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.61619703 |
41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61618065 |
42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60657774 |
43 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.57664261 |
44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.57052411 |
45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.55317416 |
46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.50688705 |
47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.46074267 |
48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.45983969 |
49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.41410721 |
50 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.40917608 |
51 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39629584 |
52 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.38896546 |
53 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.38556153 |
54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36270095 |
55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.36210485 |
56 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.34874132 |
57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33779248 |
58 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.32858934 |
59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30610944 |
60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29886726 |
61 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.29225067 |
62 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.27499916 |
63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25487281 |
64 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.24929308 |
65 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.24730354 |
66 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.24730354 |
67 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.24730354 |
68 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23184749 |
69 | MAF_26560356_Chip-Seq_TH2_Human | 1.19451652 |
70 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.18805752 |
71 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.18286063 |
72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17173375 |
73 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16994655 |
74 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14679808 |
75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13376488 |
76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13305110 |
77 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12797415 |
78 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12280581 |
79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12150256 |
80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11868243 |
81 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09975937 |
82 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08093941 |
83 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.05657039 |
84 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05325816 |
85 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.04840889 |
86 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04010142 |
87 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03618250 |
88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02573009 |
89 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.01722739 |
90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00347205 |
91 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99859537 |
92 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99095975 |
93 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98706893 |
94 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.98254473 |
95 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98108061 |
96 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97825417 |
97 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96374091 |
98 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96029421 |
99 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.95638259 |
100 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95350850 |
101 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94600791 |
102 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.93954263 |
103 | ATF3_27146783_Chip-Seq_COLON_Human | 0.93359905 |
104 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92333819 |
105 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.92172907 |
106 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.92172907 |
107 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.92104059 |
108 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.91875040 |
109 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.91815849 |
110 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91438699 |
111 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.90692937 |
112 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90114051 |
113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89604185 |
114 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89600595 |
115 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88818874 |
116 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88624428 |
117 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.86837131 |
118 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85441395 |
119 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.85176293 |
120 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84254660 |
121 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.81708825 |
122 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.81012879 |
123 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80471306 |
124 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.80466801 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000372_irregular_coat_pigmentation | 3.14880461 |
2 | MP0001835_abnormal_antigen_presentation | 2.92888823 |
3 | MP0000015_abnormal_ear_pigmentation | 2.91112296 |
4 | MP0005408_hypopigmentation | 2.79422476 |
5 | MP0000685_abnormal_immune_system | 2.64545116 |
6 | MP0005387_immune_system_phenotype | 2.56136110 |
7 | MP0001790_abnormal_immune_system | 2.56136110 |
8 | MP0003172_abnormal_lysosome_physiology | 2.41076835 |
9 | MP0005171_absent_coat_pigmentation | 2.39666166 |
10 | MP0001800_abnormal_humoral_immune | 2.39171170 |
11 | MP0005360_urolithiasis | 2.35760757 |
12 | MP0002139_abnormal_hepatobiliary_system | 2.26902432 |
13 | MP0005075_abnormal_melanosome_morpholog | 2.22641697 |
14 | MP0003436_decreased_susceptibility_to | 2.12435079 |
15 | MP0002166_altered_tumor_susceptibility | 2.08802693 |
16 | MP0003763_abnormal_thymus_physiology | 2.02960992 |
17 | MP0002452_abnormal_antigen_presenting | 1.98239653 |
18 | MP0006082_CNS_inflammation | 1.95927211 |
19 | MP0003252_abnormal_bile_duct | 1.93289518 |
20 | MP0005000_abnormal_immune_tolerance | 1.90838882 |
21 | MP0003300_gastrointestinal_ulcer | 1.88190416 |
22 | MP0002723_abnormal_immune_serum | 1.84960351 |
23 | MP0005365_abnormal_bile_salt | 1.83382035 |
24 | MP0009785_altered_susceptibility_to | 1.78370157 |
25 | MP0005671_abnormal_response_to | 1.76942672 |
26 | MP0005451_abnormal_body_composition | 1.76664549 |
27 | MP0004947_skin_inflammation | 1.76068971 |
28 | MP0005025_abnormal_response_to | 1.71482451 |
29 | MP0008260_abnormal_autophagy | 1.69380355 |
30 | MP0001819_abnormal_immune_cell | 1.66943810 |
31 | MP0002006_tumorigenesis | 1.66860267 |
32 | MP0002420_abnormal_adaptive_immunity | 1.66727230 |
33 | MP0005076_abnormal_cell_differentiation | 1.61447955 |
34 | MP0010155_abnormal_intestine_physiology | 1.60450736 |
35 | MP0002419_abnormal_innate_immunity | 1.59863453 |
36 | MP0003303_peritoneal_inflammation | 1.58789977 |
37 | MP0002148_abnormal_hypersensitivity_rea | 1.56417517 |
38 | MP0002138_abnormal_hepatobiliary_system | 1.55299764 |
39 | MP0005174_abnormal_tail_pigmentation | 1.53977768 |
40 | MP0002254_reproductive_system_inflammat | 1.53311454 |
41 | MP0005085_abnormal_gallbladder_physiolo | 1.46531390 |
42 | MP0008438_abnormal_cutaneous_collagen | 1.45762273 |
43 | MP0009840_abnormal_foam_cell | 1.45609782 |
44 | MP0002405_respiratory_system_inflammati | 1.42161438 |
45 | MP0008057_abnormal_DNA_replication | 1.41463239 |
46 | MP0002398_abnormal_bone_marrow | 1.40408387 |
47 | MP0003806_abnormal_nucleotide_metabolis | 1.40336570 |
48 | MP0002009_preneoplasia | 1.39915406 |
49 | MP0003724_increased_susceptibility_to | 1.38969268 |
50 | MP0009278_abnormal_bone_marrow | 1.38398517 |
51 | MP0003566_abnormal_cell_adhesion | 1.37573890 |
52 | MP0000716_abnormal_immune_system | 1.37447654 |
53 | MP0001845_abnormal_inflammatory_respons | 1.36413841 |
54 | MP0010352_gastrointestinal_tract_polyps | 1.35998476 |
55 | MP0003453_abnormal_keratinocyte_physiol | 1.35305048 |
56 | MP0003191_abnormal_cellular_cholesterol | 1.32940957 |
57 | MP0001873_stomach_inflammation | 1.32855850 |
58 | MP0002877_abnormal_melanocyte_morpholog | 1.31253094 |
59 | MP0003045_fibrosis | 1.30733359 |
60 | MP0003195_calcinosis | 1.30658225 |
61 | MP0009764_decreased_sensitivity_to | 1.29268492 |
62 | MP0001958_emphysema | 1.27057561 |
63 | MP0003136_yellow_coat_color | 1.26917060 |
64 | MP0000689_abnormal_spleen_morphology | 1.26873677 |
65 | MP0003705_abnormal_hypodermis_morpholog | 1.26660893 |
66 | MP0005670_abnormal_white_adipose | 1.26233817 |
67 | MP0000609_abnormal_liver_physiology | 1.26232140 |
68 | MP0005023_abnormal_wound_healing | 1.23665137 |
69 | MP0008469_abnormal_protein_level | 1.21896903 |
70 | MP0005464_abnormal_platelet_physiology | 1.18870891 |
71 | MP0002722_abnormal_immune_system | 1.17006090 |
72 | MP0001853_heart_inflammation | 1.15052799 |
73 | MP0009333_abnormal_splenocyte_physiolog | 1.13388793 |
74 | MP0000767_abnormal_smooth_muscle | 1.12482620 |
75 | MP0001533_abnormal_skeleton_physiology | 1.12266637 |
76 | MP0005058_abnormal_lysosome_morphology | 1.10156178 |
77 | MP0002429_abnormal_blood_cell | 1.09766347 |
78 | MP0003448_altered_tumor_morphology | 1.09429950 |
79 | MP0003950_abnormal_plasma_membrane | 1.07343893 |
80 | MP0005166_decreased_susceptibility_to | 1.03542622 |
81 | MP0002075_abnormal_coat/hair_pigmentati | 1.02478215 |
82 | MP0001666_abnormal_nutrient_absorption | 1.00530692 |
83 | MP0006054_spinal_hemorrhage | 0.99485571 |
84 | MP0010329_abnormal_lipoprotein_level | 0.99274094 |
85 | MP0008875_abnormal_xenobiotic_pharmacok | 0.98407901 |
86 | MP0002168_other_aberrant_phenotype | 0.98067591 |
87 | MP0010094_abnormal_chromosome_stability | 0.96898491 |
88 | MP0005257_abnormal_intraocular_pressure | 0.96519842 |
89 | MP0003943_abnormal_hepatobiliary_system | 0.96426889 |
90 | MP0002060_abnormal_skin_morphology | 0.96253029 |
91 | MP0000569_abnormal_digit_pigmentation | 0.96191918 |
92 | MP0000858_altered_metastatic_potential | 0.95539767 |
93 | MP0004264_abnormal_extraembryonic_tissu | 0.95255488 |
94 | MP0002933_joint_inflammation | 0.94798100 |
95 | MP0009763_increased_sensitivity_to | 0.94579210 |
96 | MP0003693_abnormal_embryo_hatching | 0.92546882 |
97 | MP0003279_aneurysm | 0.92355588 |
98 | MP0003075_altered_response_to | 0.92224902 |
99 | MP0002998_abnormal_bone_remodeling | 0.91787472 |
100 | MP0003091_abnormal_cell_migration | 0.91522193 |
101 | MP0002396_abnormal_hematopoietic_system | 0.91300501 |
102 | MP0000703_abnormal_thymus_morphology | 0.91082190 |
103 | MP0010234_abnormal_vibrissa_follicle | 0.90595439 |
104 | MP0002095_abnormal_skin_pigmentation | 0.89430155 |
105 | MP0004510_myositis | 0.86499003 |
106 | MP0002136_abnormal_kidney_physiology | 0.85738892 |
107 | MP0005310_abnormal_salivary_gland | 0.85646151 |
108 | MP0001915_intracranial_hemorrhage | 0.84982716 |
109 | MP0001186_pigmentation_phenotype | 0.84908342 |
110 | MP0003868_abnormal_feces_composition | 0.84299339 |
111 | MP0003186_abnormal_redox_activity | 0.83853252 |
112 | MP0003866_abnormal_defecation | 0.81747221 |
113 | MP0002928_abnormal_bile_duct | 0.81396289 |
114 | MP0008961_abnormal_basal_metabolism | 0.80733692 |
115 | MP0010368_abnormal_lymphatic_system | 0.79191862 |
116 | MP0001243_abnormal_dermal_layer | 0.79094715 |
117 | MP0001851_eye_inflammation | 0.78599792 |
118 | MP0000371_diluted_coat_color | 0.77539288 |
119 | MP0005390_skeleton_phenotype | 0.77397868 |
120 | MP0010307_abnormal_tumor_latency | 0.76084065 |
121 | MP0004381_abnormal_hair_follicle | 0.75988092 |
122 | MP0000598_abnormal_liver_morphology | 0.75080079 |
123 | MP0005319_abnormal_enzyme/_coenzyme | 0.74988801 |
124 | MP0009643_abnormal_urine_homeostasis | 0.74649406 |
125 | MP0004019_abnormal_vitamin_homeostasis | 0.74476032 |
126 | MP0004185_abnormal_adipocyte_glucose | 0.73110866 |
127 | MP0000249_abnormal_blood_vessel | 0.72046195 |
128 | MP0001545_abnormal_hematopoietic_system | 0.71535299 |
129 | MP0005397_hematopoietic_system_phenotyp | 0.71535299 |
130 | MP0004808_abnormal_hematopoietic_stem | 0.71288378 |
131 | MP0001216_abnormal_epidermal_layer | 0.69990335 |
132 | MP0005503_abnormal_tendon_morphology | 0.69962625 |
133 | MP0003111_abnormal_nucleus_morphology | 0.69798076 |
134 | MP0000490_abnormal_crypts_of | 0.69626807 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Albinism (HP:0001022) | 3.96307806 |
2 | Cutaneous melanoma (HP:0012056) | 3.92364245 |
3 | Autoimmune thrombocytopenia (HP:0001973) | 3.41818191 |
4 | Pustule (HP:0200039) | 3.37824033 |
5 | Myocardial infarction (HP:0001658) | 3.31351998 |
6 | Ocular albinism (HP:0001107) | 3.09031062 |
7 | Emphysema (HP:0002097) | 2.99421992 |
8 | Recurrent bronchitis (HP:0002837) | 2.95658857 |
9 | Eczematoid dermatitis (HP:0000976) | 2.88147542 |
10 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.84352382 |
11 | Hypoplasia of the fovea (HP:0007750) | 2.84352382 |
12 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.80168361 |
13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.80168361 |
14 | Abnormality of glycolipid metabolism (HP:0010969) | 2.80168361 |
15 | Abnormality of the fingertips (HP:0001211) | 2.78586293 |
16 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.77873855 |
17 | Malnutrition (HP:0004395) | 2.77561245 |
18 | Agammaglobulinemia (HP:0004432) | 2.73735713 |
19 | Systemic lupus erythematosus (HP:0002725) | 2.70212383 |
20 | Abnormality of macrophages (HP:0004311) | 2.69633963 |
21 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.69015792 |
22 | Loss of speech (HP:0002371) | 2.66480610 |
23 | Recurrent fungal infections (HP:0002841) | 2.65379987 |
24 | Abnormal gallbladder physiology (HP:0012438) | 2.62286994 |
25 | Cholecystitis (HP:0001082) | 2.62286994 |
26 | Mitral stenosis (HP:0001718) | 2.60504474 |
27 | Recurrent viral infections (HP:0004429) | 2.58975803 |
28 | Gingival bleeding (HP:0000225) | 2.58518395 |
29 | Myositis (HP:0100614) | 2.57354787 |
30 | Colitis (HP:0002583) | 2.57206813 |
31 | White forelock (HP:0002211) | 2.54046642 |
32 | Vasculitis (HP:0002633) | 2.53633010 |
33 | Cerebral aneurysm (HP:0004944) | 2.51622974 |
34 | Congenital sensorineural hearing impairment (HP:0008527) | 2.50000277 |
35 | Spontaneous hematomas (HP:0007420) | 2.49492871 |
36 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.48028205 |
37 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.47820758 |
38 | Patchy hypopigmentation of hair (HP:0011365) | 2.46208712 |
39 | Orchitis (HP:0100796) | 2.45359794 |
40 | Aortic aneurysm (HP:0004942) | 2.44980464 |
41 | Iris hypopigmentation (HP:0007730) | 2.43855645 |
42 | Deep venous thrombosis (HP:0002625) | 2.43689420 |
43 | Generalized hypopigmentation (HP:0007513) | 2.42211182 |
44 | Complement deficiency (HP:0004431) | 2.40880408 |
45 | Stomatitis (HP:0010280) | 2.40487707 |
46 | Recurrent abscess formation (HP:0002722) | 2.39746159 |
47 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.39203913 |
48 | Abnormality of T cell number (HP:0011839) | 2.36448311 |
49 | Nasal polyposis (HP:0100582) | 2.35321164 |
50 | Chronic otitis media (HP:0000389) | 2.34537530 |
51 | Inflammation of the large intestine (HP:0002037) | 2.32468265 |
52 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.32145037 |
53 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.30912619 |
54 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.30505029 |
55 | Osteolytic defects of the hand bones (HP:0009699) | 2.30505029 |
56 | Recurrent bacterial skin infections (HP:0005406) | 2.29819863 |
57 | Hypobetalipoproteinemia (HP:0003563) | 2.26084636 |
58 | Gastrointestinal inflammation (HP:0004386) | 2.25399842 |
59 | Chronic diarrhea (HP:0002028) | 2.25360390 |
60 | T lymphocytopenia (HP:0005403) | 2.23594686 |
61 | Abnormality of the nasal mucosa (HP:0000433) | 2.20082337 |
62 | Intrahepatic cholestasis (HP:0001406) | 2.18234879 |
63 | Dysostosis multiplex (HP:0000943) | 2.18002794 |
64 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.17695127 |
65 | Periodontitis (HP:0000704) | 2.17042404 |
66 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.17010443 |
67 | Recurrent cutaneous fungal infections (HP:0011370) | 2.17010443 |
68 | Lip pit (HP:0100267) | 2.16594735 |
69 | Joint hemorrhage (HP:0005261) | 2.15726796 |
70 | Hypokinesia (HP:0002375) | 2.14277838 |
71 | Nephritis (HP:0000123) | 2.13534437 |
72 | Alopecia of scalp (HP:0002293) | 2.12469284 |
73 | Glomerulonephritis (HP:0000099) | 2.11325261 |
74 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.11289554 |
75 | Gastrointestinal stroma tumor (HP:0100723) | 2.11226007 |
76 | Broad metatarsal (HP:0001783) | 2.11020615 |
77 | Vacuolated lymphocytes (HP:0001922) | 2.08024605 |
78 | Increased IgE level (HP:0003212) | 2.06075219 |
79 | Optic neuritis (HP:0100653) | 2.06043038 |
80 | Retrobulbar optic neuritis (HP:0100654) | 2.06043038 |
81 | Pulmonary infiltrates (HP:0002113) | 2.05395765 |
82 | Poikiloderma (HP:0001029) | 2.03703952 |
83 | Xanthomatosis (HP:0000991) | 2.03676151 |
84 | Pulmonary artery stenosis (HP:0004415) | 2.03434084 |
85 | IgA deficiency (HP:0002720) | 2.03166740 |
86 | Gangrene (HP:0100758) | 2.02390248 |
87 | Esophageal varix (HP:0002040) | 2.01983051 |
88 | Lymphopenia (HP:0001888) | 1.98802755 |
89 | Abnormality of complement system (HP:0005339) | 1.98309102 |
90 | Mediastinal lymphadenopathy (HP:0100721) | 1.98110861 |
91 | Arterial thrombosis (HP:0004420) | 1.96765583 |
92 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.96370816 |
93 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.96149614 |
94 | Entropion (HP:0000621) | 1.95541286 |
95 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.95452425 |
96 | Recurrent skin infections (HP:0001581) | 1.95154284 |
97 | Encephalitis (HP:0002383) | 1.94901930 |
98 | IgM deficiency (HP:0002850) | 1.94070348 |
99 | Cellulitis (HP:0100658) | 1.93853003 |
100 | Abnormal tarsal ossification (HP:0008369) | 1.93551343 |
101 | Increased IgM level (HP:0003496) | 1.93111241 |
102 | Spondylolisthesis (HP:0003302) | 1.92075183 |
103 | Hematochezia (HP:0002573) | 1.91603907 |
104 | Joint swelling (HP:0001386) | 1.90795869 |
105 | Eosinophilia (HP:0001880) | 1.90343155 |
106 | Prolonged partial thromboplastin time (HP:0003645) | 1.88662576 |
107 | Abnormality of the fovea (HP:0000493) | 1.87316730 |
108 | Restrictive lung disease (HP:0002091) | 1.85410266 |
109 | Leukocytosis (HP:0001974) | 1.84992196 |
110 | Small epiphyses (HP:0010585) | 1.84970151 |
111 | Keratoconjunctivitis sicca (HP:0001097) | 1.84815144 |
112 | Recurrent sinusitis (HP:0011108) | 1.84078195 |
113 | Lower limb hyperreflexia (HP:0002395) | 1.83886609 |
114 | Aortic dissection (HP:0002647) | 1.82867313 |
115 | Blue irides (HP:0000635) | 1.82120378 |
116 | Gingivitis (HP:0000230) | 1.82022273 |
117 | Abnormality of T cells (HP:0002843) | 1.81141674 |
118 | Combined immunodeficiency (HP:0005387) | 1.80891846 |
119 | Abnormality of lateral ventricle (HP:0030047) | 1.79910468 |
120 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.77867687 |
121 | Mucopolysacchariduria (HP:0008155) | 1.77867687 |
122 | Keratitis (HP:0000491) | 1.77179821 |
123 | Aneurysm (HP:0002617) | 1.76627389 |
124 | Osteomyelitis (HP:0002754) | 1.76470058 |
125 | Hydroxyprolinuria (HP:0003080) | 1.76139392 |
126 | Abnormality of proline metabolism (HP:0010907) | 1.76139392 |
127 | Meningitis (HP:0001287) | 1.75844098 |
128 | Hypoproteinemia (HP:0003075) | 1.75674301 |
129 | Epidermoid cyst (HP:0200040) | 1.75520136 |
130 | Tongue fasciculations (HP:0001308) | 1.75136576 |
131 | Parakeratosis (HP:0001036) | 1.74541440 |
132 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.74433750 |
133 | Thin bony cortex (HP:0002753) | 1.74084115 |
134 | Fatigue (HP:0012378) | 1.73735442 |
135 | Leukopenia (HP:0001882) | 1.73563223 |
136 | Abnormality of the preputium (HP:0100587) | 1.73474356 |
137 | Thick nail (HP:0001805) | 1.72664570 |
138 | Increased CSF protein (HP:0002922) | 1.72292409 |
139 | Hypochromic anemia (HP:0001931) | 1.71893266 |
140 | Turricephaly (HP:0000262) | 1.70109864 |
141 | Chronic sinusitis (HP:0011109) | 1.68238752 |
142 | Epistaxis (HP:0000421) | 1.67716532 |
143 | Abnormal platelet volume (HP:0011876) | 1.66979027 |
144 | Hypergammaglobulinemia (HP:0010702) | 1.66615469 |
145 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.66317541 |
146 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.65778289 |
147 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.65778289 |
148 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.65778289 |
149 | Polycythemia (HP:0001901) | 1.65286397 |
150 | Hemoptysis (HP:0002105) | 1.65032140 |
151 | Abnormality of the common coagulation pathway (HP:0010990) | 1.64952003 |
152 | Hypochromic microcytic anemia (HP:0004840) | 1.64348462 |
153 | Aortic regurgitation (HP:0001659) | 1.64291063 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIM28 | 3.49117093 |
2 | ERN1 | 3.37237197 |
3 | MAP4K1 | 3.28549405 |
4 | MAP3K14 | 3.06745988 |
5 | TYK2 | 3.00565161 |
6 | CDK12 | 2.84047283 |
7 | FGFR4 | 2.74599450 |
8 | STK38L | 2.57127928 |
9 | SMG1 | 2.39278923 |
10 | JAK3 | 2.38137447 |
11 | MAP3K10 | 2.21105326 |
12 | JAK1 | 2.09962027 |
13 | EPHA3 | 2.09404856 |
14 | IKBKE | 2.07554569 |
15 | MAP3K13 | 1.91953923 |
16 | TGFBR2 | 1.90553428 |
17 | EIF2AK3 | 1.88266379 |
18 | TBK1 | 1.87526267 |
19 | STK10 | 1.86859542 |
20 | PRPF4B | 1.79156284 |
21 | TXK | 1.76674844 |
22 | CSK | 1.70443574 |
23 | EIF2AK1 | 1.70396015 |
24 | IKBKB | 1.68312272 |
25 | CHUK | 1.64208219 |
26 | SIK1 | 1.58418038 |
27 | PASK | 1.57416317 |
28 | BLK | 1.55674163 |
29 | IRAK3 | 1.54832643 |
30 | ZAP70 | 1.47563158 |
31 | FRK | 1.37385678 |
32 | MAPK15 | 1.37317871 |
33 | FER | 1.36068452 |
34 | TAOK3 | 1.34133616 |
35 | FGFR3 | 1.30442761 |
36 | ITK | 1.28747166 |
37 | PTK6 | 1.24133088 |
38 | RIPK1 | 1.23725609 |
39 | KIT | 1.20157210 |
40 | NME2 | 1.18667088 |
41 | ICK | 1.17225634 |
42 | TAOK1 | 1.16604762 |
43 | EPHB1 | 1.15845588 |
44 | SIK3 | 1.12236794 |
45 | BTK | 1.11841531 |
46 | CSF1R | 1.07510583 |
47 | BRD4 | 1.06560905 |
48 | TSSK6 | 1.06327811 |
49 | NEK9 | 1.05875920 |
50 | BMX | 1.05685422 |
51 | HCK | 1.04707597 |
52 | BUB1 | 1.04395272 |
53 | FLT3 | 1.03108713 |
54 | GRK6 | 1.02488018 |
55 | CAMK1D | 1.02417859 |
56 | NLK | 1.01679919 |
57 | LCK | 1.00283982 |
58 | PAK4 | 1.00245861 |
59 | RIPK4 | 0.99429680 |
60 | LATS1 | 0.98325193 |
61 | PKN2 | 0.97308644 |
62 | STK38 | 0.96628884 |
63 | MARK3 | 0.95920240 |
64 | PRKCI | 0.92638721 |
65 | PIM1 | 0.91472733 |
66 | IRAK4 | 0.90293670 |
67 | PDGFRA | 0.90116599 |
68 | MAPK11 | 0.90039998 |
69 | EEF2K | 0.87982281 |
70 | ACVR1B | 0.86783293 |
71 | TTN | 0.86733850 |
72 | BRSK2 | 0.86607029 |
73 | INSRR | 0.85818238 |
74 | TRIB3 | 0.84707582 |
75 | TRPM7 | 0.84015008 |
76 | FGFR2 | 0.83646487 |
77 | STK39 | 0.83169893 |
78 | MTOR | 0.79639043 |
79 | MAP2K3 | 0.79504637 |
80 | STK3 | 0.77388221 |
81 | MAP3K7 | 0.75361449 |
82 | IRAK2 | 0.73362475 |
83 | JAK2 | 0.71539425 |
84 | CDK6 | 0.71009036 |
85 | NUAK1 | 0.70870267 |
86 | SYK | 0.67305799 |
87 | DDR2 | 0.66891513 |
88 | DYRK1B | 0.65969090 |
89 | SIK2 | 0.65581743 |
90 | MAPKAPK3 | 0.63548444 |
91 | GSK3A | 0.63456902 |
92 | MAP3K3 | 0.62897656 |
93 | STK24 | 0.62566602 |
94 | EPHA2 | 0.62187203 |
95 | LYN | 0.62066928 |
96 | LRRK2 | 0.61798568 |
97 | BRSK1 | 0.61326492 |
98 | TAOK2 | 0.59616703 |
99 | MAPK7 | 0.59124944 |
100 | HIPK2 | 0.58042889 |
101 | RPS6KA4 | 0.57864282 |
102 | MELK | 0.57760555 |
103 | FGR | 0.57639565 |
104 | CDC42BPA | 0.57583706 |
105 | WEE1 | 0.55810687 |
106 | PTK2 | 0.54617329 |
107 | VRK2 | 0.54238294 |
108 | PDGFRB | 0.52533396 |
109 | KDR | 0.52332862 |
110 | PRKD2 | 0.51597854 |
111 | TNK2 | 0.51203934 |
112 | STK4 | 0.51120269 |
113 | EPHB2 | 0.50507271 |
114 | CAMK1G | 0.50499376 |
115 | CDK4 | 0.48453632 |
116 | ABL1 | 0.47512170 |
117 | PRKCQ | 0.47465246 |
118 | MST1R | 0.47303772 |
119 | CDK9 | 0.45816443 |
120 | TEC | 0.45279860 |
121 | YES1 | 0.44990049 |
122 | PRKD3 | 0.44916956 |
123 | CDK7 | 0.43268553 |
124 | MST4 | 0.42682592 |
125 | MAP2K2 | 0.41816967 |
126 | INSR | 0.40224770 |
127 | EGFR | 0.39056919 |
128 | IRAK1 | 0.37792228 |
129 | PIK3CG | 0.37702308 |
130 | MAPKAPK2 | 0.37650326 |
131 | BMPR2 | 0.37573156 |
132 | MAP3K1 | 0.36700552 |
133 | TGFBR1 | 0.34939255 |
134 | PRKAA2 | 0.34409669 |
135 | PAK3 | 0.32554894 |
136 | MAP3K12 | 0.32317592 |
137 | PRKCH | 0.30528188 |
138 | MAP3K8 | 0.30458668 |
139 | BCR | 0.30264129 |
140 | PDPK1 | 0.28346068 |
141 | FGFR1 | 0.27792297 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.50324621 |
2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.42372939 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.39600010 |
4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.27535119 |
5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.22770941 |
6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.05325190 |
7 | Measles_Homo sapiens_hsa05162 | 1.96954171 |
8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.92305161 |
9 | Asthma_Homo sapiens_hsa05310 | 1.89651141 |
10 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.85647472 |
11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.84790756 |
12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.84715054 |
13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.81553625 |
14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.78536468 |
15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.73405785 |
16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.71038565 |
17 | Lysine degradation_Homo sapiens_hsa00310 | 1.70809713 |
18 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.60672077 |
19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.54671106 |
20 | Proteasome_Homo sapiens_hsa03050 | 1.53566849 |
21 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.52081417 |
22 | Influenza A_Homo sapiens_hsa05164 | 1.51112002 |
23 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.47935328 |
24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.47878390 |
25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.45290616 |
26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.45029043 |
27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.42560380 |
28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42061710 |
29 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.40682764 |
30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.39157996 |
31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35095036 |
32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.33270826 |
33 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.32297048 |
34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.31625030 |
35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.28869459 |
36 | ABC transporters_Homo sapiens_hsa02010 | 1.23473825 |
37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.20665068 |
38 | Apoptosis_Homo sapiens_hsa04210 | 1.20299549 |
39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.20238933 |
40 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.17044901 |
41 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.15303830 |
42 | Hepatitis C_Homo sapiens_hsa05160 | 1.14431517 |
43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.13327532 |
44 | Allograft rejection_Homo sapiens_hsa05330 | 1.12292178 |
45 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.11548910 |
46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.07307958 |
47 | Legionellosis_Homo sapiens_hsa05134 | 1.05240844 |
48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05048350 |
49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03956678 |
50 | Hepatitis B_Homo sapiens_hsa05161 | 1.00446324 |
51 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.99909856 |
52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98368296 |
53 | Malaria_Homo sapiens_hsa05144 | 0.97826692 |
54 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.97493652 |
55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.97406834 |
56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.96530440 |
57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94737686 |
58 | Adherens junction_Homo sapiens_hsa04520 | 0.92442807 |
59 | Pertussis_Homo sapiens_hsa05133 | 0.92421737 |
60 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92397851 |
61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91747412 |
62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.91552949 |
63 | Galactose metabolism_Homo sapiens_hsa00052 | 0.91483233 |
64 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.89940908 |
65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89472406 |
66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.87926855 |
67 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.86570196 |
68 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86199736 |
69 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.86176436 |
70 | Tuberculosis_Homo sapiens_hsa05152 | 0.84097653 |
71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82855174 |
72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82504180 |
73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80006912 |
74 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79661045 |
75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79451806 |
76 | Shigellosis_Homo sapiens_hsa05131 | 0.78399014 |
77 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75848082 |
78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.75599242 |
79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73904204 |
80 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71783775 |
81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71761177 |
82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71568286 |
83 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.71228485 |
84 | Insulin resistance_Homo sapiens_hsa04931 | 0.71060543 |
85 | Lysosome_Homo sapiens_hsa04142 | 0.70865778 |
86 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70499679 |
87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.68859978 |
88 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.67400688 |
89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67273410 |
90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.66294162 |
91 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.65086567 |
92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65070235 |
93 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.63755971 |
94 | Prostate cancer_Homo sapiens_hsa05215 | 0.62347917 |
95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61732559 |
96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61439004 |
97 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.60606350 |
98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59907229 |
99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59842567 |
100 | Amoebiasis_Homo sapiens_hsa05146 | 0.58597804 |
101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58558251 |
102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58210033 |
103 | Bile secretion_Homo sapiens_hsa04976 | 0.57640007 |
104 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.56095589 |
105 | Prion diseases_Homo sapiens_hsa05020 | 0.54271661 |
106 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53923051 |
107 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53602816 |
108 | Peroxisome_Homo sapiens_hsa04146 | 0.52995420 |
109 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.52241708 |
110 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51984483 |
111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51587307 |
112 | Bladder cancer_Homo sapiens_hsa05219 | 0.49966523 |
113 | Phagosome_Homo sapiens_hsa04145 | 0.49769838 |
114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47715311 |
115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47106539 |
116 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.45434452 |
117 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45089070 |
118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44910972 |
119 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44132281 |
120 | Salmonella infection_Homo sapiens_hsa05132 | 0.43908072 |
121 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.43662529 |
122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42469828 |
123 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42172257 |
124 | Focal adhesion_Homo sapiens_hsa04510 | 0.41846227 |
125 | Pathways in cancer_Homo sapiens_hsa05200 | 0.41582126 |
126 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41563702 |
127 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.40181980 |
128 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.37168678 |
129 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35908187 |
130 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34776989 |
131 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33570495 |
132 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31525107 |